Mesoblast Limited (NASDAQ:MESO) saw an upside of 8.82% to close Tuesday at $1.48 after adding $0.12 on the day. The 5-day average trading volume is 781,760 shares of the company’s common stock. It has gained $1.5000 in the past week and touched a new high 3 times within the past 5 days. An average of 1,083,040 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 581,112.
MESO’s 1-month performance is -68.58% or -$3.3500 on its low of $1.1552 reached on 08/11/23. The company’s shares have touched a 52-week low of $1.16 and high of $5.12, with the stock’s rally to the 52-week high happening on 07/17/23. YTD, MESO has lost -49.14% or -$1.4300 and has reached a new high 21 times. However, the current price is down -71.09% from the 52-week high price.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Valuation Metrics
MESO stock has a beta of 3.39. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 29.14 while the price-to-book (PB) in the most recent quarter is 0.45.
Mesoblast Limited’s quick ratio for the period ended March 30 was 1.10, with the current ratio over the same period at 1.10. As well, the company’s long term debt to equity for the quarter ending March 30 was 0.22, while the total debt to equity was 0.24. The firm’s gross profit as reported stood at -$20.54 million against revenue of $10.21 million.
Earnings Surprise
For the quarterly period ending March 30 this year, Net income and sales went down compared to those figures reported in the previous quarter. Net income shrunk -8.17% to -$91.35 million, while revenue of $0.0 was 100.0% off the previous quarter. Analysts expected MESO to announce -$0.17 per share in earnings in its latest quarter, but it posted -$0.13, representing a 23.50% surprise. EBITDA for the quarter stood at more than -$12.67 million. MESO stock balance sheet for the quarter ending March 30 shows that total liabilities totaled 168.27 million, with total debt at $114.61 million.
Let’s look briefly at Mesoblast Limited (MESO) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 28.82% to suggest the stock is trending oversold, with historical volatility in this time period at 60.03%.
The stock’s 5-day moving average is $1.3260, reflecting a +16.54% or $0.2100 change from its current price. MESO is currently trading -69.36% above its 20-day SMA, -51.95% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -58.77% and SMA200 by-50.67%.
Stochastic %K and %D was 7.08% and 4.86% and the average true range (ATR) pointed at 0.2331. The RSI (14) points at 26.81%, while the 14-day stochastic is at 11.39% with the period’s ATR at 0.2577. The stock’s 9-day MACD Oscillator is pointing at 0.0722 and -0.1540 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Mesoblast Limited (NASDAQ: MESO), Maxim Group downgraded it to a Hold rating. They previously had a Buy rating on the stock. Analysts offering their rating for MESO stock have a consensus rating for the stock as Hold. Currently, 1 brokerage advisors rate MESO as a “sell,”, while 5 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 1 have offered a “buy” rating.
What is MESO’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $1.50 and a high of $23.00, with their median price target at $2.47. Looking at these predictions, the average price target given by analysts is for Mesoblast Limited (MESO) stock is $6.90.
